197 related articles for article (PubMed ID: 25833404)
21. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
Chen X; He J; Liu J; You Y; Yuan L; Wen Y
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
[TBL] [Abstract][Full Text] [Related]
22. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
23. A report of rifampin-resistant leprosy from northern and eastern India: identification and in silico analysis of molecular interactions.
Vedithi SC; Lavania M; Kumar M; Kaur P; Turankar RP; Singh I; Nigam A; Sengupta U
Med Microbiol Immunol; 2015 Apr; 204(2):193-203. PubMed ID: 25201810
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
25. Insights into the drug resistance induced by the BaDHPS mutations: molecular dynamic simulations and MM/GBSA studies.
Chu WT; Zhang JL; Zheng QC; Chen L; Xue Q; Zhang HX
J Biomol Struct Dyn; 2013 Oct; 31(10):1127-36. PubMed ID: 23030549
[TBL] [Abstract][Full Text] [Related]
26. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
27. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
[TBL] [Abstract][Full Text] [Related]
28. Computational Simulation Techniques to Understand Rifampicin Resistance Mutation (S425L) of rpoB in M. leprae.
Nisha J; Shanthi V
J Cell Biochem; 2015 Jul; 116(7):1278-85. PubMed ID: 25676141
[TBL] [Abstract][Full Text] [Related]
29. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis.
Gengenbacher M; Xu T; Niyomrattanakit P; Spraggon G; Dick T
FEMS Microbiol Lett; 2008 Oct; 287(1):128-35. PubMed ID: 18680522
[TBL] [Abstract][Full Text] [Related]
31. A new
Maladan Y; Krismawati H; Hutapea HML; Oktavian A; Fatimah R; Widodo
Heliyon; 2019 Mar; 5(3):e01279. PubMed ID: 31016254
[TBL] [Abstract][Full Text] [Related]
32. A theoretical study of chemical bonding and topological and electrostatic properties of the anti-leprosy drug dapsone.
Rajendran ND; Mookan N; Samuel I; Mookan SB; Munusamy G; Gurudeeban S; Kaliamurthi S
J Mol Model; 2020 May; 26(6):138. PubMed ID: 32415338
[TBL] [Abstract][Full Text] [Related]
33. Evidence for
Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation.
Nisha J; Shanthi V
Cell Biochem Biophys; 2018 Jun; 76(1-2):125-134. PubMed ID: 28822069
[TBL] [Abstract][Full Text] [Related]
35. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Chakraborty A; Ghosh R; Biswas A
FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
[TBL] [Abstract][Full Text] [Related]
36. Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli.
Nopponpunth V; Sirawaraporn W; Greene PJ; Santi DV
J Bacteriol; 1999 Nov; 181(21):6814-21. PubMed ID: 10542185
[TBL] [Abstract][Full Text] [Related]
37. Ribonucleotide reductase as a drug target against drug resistance Mycobacterium leprae: A molecular docking study.
Mohanty PS; Bansal AK; Naaz F; Gupta UD; Dwivedi VD; Yadava U
Infect Genet Evol; 2018 Jun; 60():58-65. PubMed ID: 29454978
[TBL] [Abstract][Full Text] [Related]
38. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
39. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
40. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
